Related references
Note: Only part of the references are listed.Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
Aakriti Dubey et al.
CURRENT MICROBIOLOGY (2022)
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus
Wenjuan Dong et al.
JOURNAL OF VIROLOGY (2022)
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni et al.
NATURE (2022)
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Lihong Liu et al.
NATURE (2022)
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Mahesh S. Dhar et al.
SCIENCE (2021)
Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19
Suchitra Kamle et al.
JCI INSIGHT (2021)
Discovery of Kasugamycin as a Potent Inhibitor of Glycoside Hydrolase Family 18 Chitinases
Huitang Qi et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
Richard Copin et al.
CELL (2021)
Confronting the Delta Variant of SARS-CoV-2, Summer 2021
Carlos del Rio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity
Junxian Ou et al.
JOURNAL OF VIROLOGY (2021)
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
Aziz Sheikh et al.
LANCET (2021)
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
M. P. O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker
Jayanthi Shastri et al.
FRONTIERS IN MEDICINE (2021)
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlcochova et al.
NATURE (2021)
Evolution patterns of SARS-CoV-2: Snapshot on its genome variants
Marta Giovanetti et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium
Haijun Zhang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade
B. Coutard et al.
ANTIVIRAL RESEARCH (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
What we know so far: COVID-19 current clinical knowledge and research
Mary A. Lake
CLINICAL MEDICINE (2020)
Angiotensin-converting enzyme 2 (ACE2),SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)
Arno R. Bourgonje et al.
JOURNAL OF PATHOLOGY (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Extrapulmonary manifestations of COVID-19
Aakriti Gupta et al.
NATURE MEDICINE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
Emma S. Winkler et al.
NATURE IMMUNOLOGY (2020)
Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease
Yang Zhou et al.
JOURNAL OF IMMUNOLOGY (2018)
Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner
Smita Gopinath et al.
NATURE MICROBIOLOGY (2018)
Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
Wenfei Song et al.
PLOS PATHOGENS (2018)
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Jean Kaoru Millet et al.
VIRUS RESEARCH (2015)
Chitinase 3-like 1 Suppresses Injury and Promotes Fibroproliferative Responses in Mammalian Lung Fibrosis
Yang Zhou et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2
Chuan Hua He et al.
CELL REPORTS (2013)
Chitinase 3-like-1 Promotes Streptococcus pneumoniae Killing and Augments Host Tolerance to Lung Antibacterial Responses
Charles S. Dela Cruz et al.
CELL HOST & MICROBE (2012)
Chitinase 1 Is a Biomarker for and Therapeutic Target in Scleroderma-Associated Interstitial Lung Disease That Augments TGF-β1 Signaling
Chun Geun Lee et al.
JOURNAL OF IMMUNOLOGY (2012)
Role of Breast Regression Protein-39 in the Pathogenesis of Cigarette Smoke-Induced Inflammation and Emphysema
Hiroshi Matsuura et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury
Chun Geun Lee et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Role of breast regression protein-39/YKL-40 in asthma and allergic responses
Chun Geun Lee et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2010)
Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis
Chun Geun Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Chitin, Chitinases and Chitinase-like Proteins in Allergic Inflammation and Tissue Remodeling
Chun Geun Lee
YONSEI MEDICAL JOURNAL (2009)
Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice
Min-Jong Kang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Serum YKL-40 levels in patients with coronary artery disease
Mine Kucur et al.
CORONARY ARTERY DISEASE (2007)
Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β1-induced pulmonary fibrosis
CG Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)